Torthaí cuardaigh - Courèche Kaderbhaï

  • 1 - 5 toradh as 5 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer

    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer de réir Courèche Kaderbhaï, Zoé Tharin, François Ghiringhelli

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies

    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies de réir Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Antibiotic Use Does Not Appear to Influence Response to Nivolumab

    Antibiotic Use Does Not Appear to Influence Response to Nivolumab de réir Courèche Kaderbhaï, Corentin Richard, Jean David Fumet, Anne Aarnink, Pascal Foucher, Bruno Coudert, Laure Favier, Aurélie Lagrange, Emeric Limagne, Romain Boidot, François Ghiringhelli

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma

    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma de réir Aurélie Bertaut, Caroline Truntzer, Rachid Madkouri, Courèche Kaderbhaï, Valentin Dérangère, Julie Vincent, Bruno Chauffert, Marie Hélène Aubriot-Lorton, Wahlid Farah, Klaus Luc Mourier, Romain Boidot, François Ghiringhelli

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer de réir Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, Silvia Ilie, Audrey Hennequin, Manon Réda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: